Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 02:18 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Buspirone as a Potential Treatment for Recurrent Central Apnea
NCT00746954 · VA Office of Research and Development · PHASE3 · terminated · last registry update 2016-03-14 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Patient recruitment and Funding inadequate to finish trial” | – | Registry record, VA Office of Research and Development |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CA1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2017-02-10Also stopped (withdrawn): Georgetown University, acetazolamide + Quinine (NCT02276989)
- 2017-01-24Also stopped (withdrawn): NYU Langone Health, Acetazolamide (NCT02670096)
- 2016-10-26Phase 3 first posted: Universidad Peruana Cayetano Heredia, Acetazolamide + Dexamethasone (NCT02945527)
- 2016-09-16Phase 3 first posted: Mayo Clinic, Diazepam + Acetazolamide (NCT02904265)
- 2016-07-13Phase 3 first posted: Boehringer Ingelheim, Loxoprofen sodium + Methocarbamol (NCT02831569)
- 2016-04-28Phase 3 first posted: University of Zurich, Acetazolamide + Placebo (NCT02755298)
- 2016-04-28Phase 3 first posted: University of Zurich, Acetazolamide + Placebo (NCT02755259)
- 2015-12-30Phase 3 first posted: Tanta University, Methocarbamol + Calcium Carbonate (NCT02642874)
- 2015-12-15Results posted on the registry: University of Florida, Diphenhydramine + Pantoprazole (NCT02142712)
- 2015-11-13Phase 3 first posted: Stanford University, Budesonide + Acetazolamide (NCT02604173)
- 2015-09-24Also stopped (withdrawn): University of Florida, Acetazolamide + Nimodipine (NCT02165644)
- 2015-06-26Also stopped (withdrawn): US Department of Veterans Affairs, acetazolamide (NCT00108602)
- 2015-06-04Results posted on the registry: Rabin Medical Center, Furosemide first, then Acetazolamide + Acetazolamide first, then Furosemide (NCT01146288)
- 2015-04-27Also stopped (withdrawn): Merck Sharp & Dohme LLC, MK-0663B + DOLOCAM PLUS® (NCT01979510)
- 2015-03-17Phase 3 first posted: University of Miami, Latanoprost + Bimatoprost (NCT02390284)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision